HomeNews

News

Rusfertide Earns Breakthrough Remedy Designation in Polycythemia Vera

The FDA granted rusfertide breakthrough remedy designation for sufferers with polycythemia vera.An investigational drug known as rusfertide might quickly supply a brand new...

Biopsy Alone Could Miss Danger in Grade Group 1 Prostate Most cancers

Dr. Neal Patel says biopsy outcomes might not absolutely seize prostate most cancers danger, stressing that PSA, stage and illness quantity also needs...

Discover Your Personal Metaphors: Recommendation For Most cancers Survivors

One thing that helped me throughout the therapeutic yr of my therapy for breast most cancers was the best way I framed the...

HMAs Underutilized in Older, Feminine and Non-White Sufferers with MDS

Hypomethylating brokers are underutilized, notably amongst older, feminine and non-White sufferers with MDS: © inventory.adobe.com.Amongst sufferers with high-risk myelodysplastic syndromes (MDS), guideline-recommended therapy...

DecisionDx-SCC Check Helps Predict Outcomes in Excessive-Danger Pores and skin Most cancers

DecisionDx-SCC might assist medical doctors extra precisely information remedy in high-risk cutaneous squamous cell carcinoma, the second most typical type of pores and...

Hot Topics